ArticleGeburtshilfe und Frauenheilkunde2013
S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013.
Article in Geburtshilfe und Frauenheilkunde, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Trial
- Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study.British journal of cancer · 2015Trial
- VEGF-C serum level is associated with response to bevacizumab maintenance therapy in primary ovarian cancer patients.PloS one · 2022Article
- Article
- Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors.International journal of molecular sciences · 2020Article
- Prescription of hormone replacement therapy prior to and after the diagnosis of gynecological cancers in German patients.Journal of cancer research and clinical oncology · 2020Article
- Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies.Journal of neurology · 2018Observational
- Non-small cell neuroendocrine carcinoma of the ovary in aOncology letters · 2018Article
- VEGF-C expression attributes the risk for lymphatic metastases to ovarian cancer patients.Oncotarget · 2017Article
- Incidental (Prophylactic) Salpingectomy at Benign Gynecologic Surgery and Cesarean Section: a Survey of Practice in Austria.Geburtshilfe und Frauenheilkunde · 2016Article
- The Clinical Relevance of Beta Blockers in Ovarian Carcinoma: A Systematic Review.Geburtshilfe und Frauenheilkunde · 2016Review
- Isolated subcutaneous implantation of a borderline ovarian tumor: A case report and review of the literature.World journal of clinical oncology · 2016Article
- Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.Oncotarget · 2016Article
- Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer.Geburtshilfe und Frauenheilkunde · 2016Article
- E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer.British journal of cancer · 2016Article
- Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients.British journal of cancer · 2015Article
- Quality Assurance for Patients with Breast Cancer - the Impact of Clinical Cancer Registries.Geburtshilfe und Frauenheilkunde · 2014Article
- DGGG Guidelines Programme: Status Quo - Quo Vadis!Geburtshilfe und Frauenheilkunde · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
35 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.